Medical science Pharmaceutical Physicians 
PM360
NOVEMBER 29, 2022
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. The solution may lie in another technology that is already being used successfully by other areas of the life sciences organization: artificial intelligence (AI).
Pharmaceutical Representative Training
JANUARY 11, 2021
What is a pharmaceutical sales representative? Pharmaceutical sales representatives (often times referred to as pharma reps) are hired by pharmaceutical/biotech companies to educate healthcare providers (HCPs) such as physicians, pharmacists, nurses, and physician assistants (PAs) on their company’s product.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
DECEMBER 20, 2024
I think that it’s very important for biosimilars that health plans allow physicians to prescribe the biosimilar, or at least provide an option of a biosimilar as that first-line treatment, Chambers said. Tony Salicos, Senior Director, National Accounts, Phathom Pharmaceuticals Samantha Theisen, Associate, U.S.
Evolve Your Success
OCTOBER 31, 2023
He provides a fascinating glimpse into what it takes to excel in the field of medical device sales, emphasizing the importance of authenticity and passion. The perfect blend of persistent dedication, a heartwarming touch of southern hospitality, and an innate understanding of the needs of both physicians and patients. I find Dr. B.
PM360
APRIL 22, 2024
Medical science Liaisons know that change is coming; How are they cashing in? Medical science liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering. Yet, can anyone be certain that this highly valuable currency is being spent wisely?
PM360
SEPTEMBER 15, 2022
More than ever, physician time is at a premium. Heavy patient loads, paperwork, research, presentations at medical meetings, and department/academic obligations make it tough to keep up with the literature, new therapies, and understanding of how community level and peers manage their patients.
PM360
JUNE 26, 2023
And while it is still too early to predict exactly how generative AI/LLMs will specifically impact pharmaceutical commercialization, several promising use cases are already emerging. Given the enormous hype that has been generated around AI in recent months, it’s easy to lose sight of just how diverse and dynamic LLM technology can be.
Expert insights. Personalized for you.
95 
Let's personalize your content